Rat Model Market Worth 588.9 Million USD by 2021

The Rat Model Market is expected to reach USD 588.9 Million by 2021 from USD 387.7 Million in 2016, growing at a CAGR of 8.7%

According to a new market research report “Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User – Global Forecast to 2021″ published by MarketsandMarkets.

Rat Model Market

                                                                  Rat Model Market

Browse 132 market data Tables and 47 Figures spread through 253 Pages and in-depth TOC on “Rat Model Market

http://www.marketsandmarkets.com/Market-Reports/rat-model-market-76036494.html

The report global Rat Model Market analyzes and studies the major market drivers, restraints/challenges, and opportunities for the forecast period of 2016 to 2021. The global Rat Model Market is segmented on the basis of model type, service, therapeutic area, technology, end user, care product, and region.

On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global Rat Model Market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

Inquiry Details:

http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=76036494

Major Market Developments Rat Model;

  • In August 2016, Charles River Laboratories, Inc. entered into a strategic partnership with The Milner Therapeutics Institute and Consortium (UK). This partnership with the Consortium allows the academic institutions access to Charles River’s early discovery and drug development and services for the early stage drug development processes.
  • In September, 2016, Charles River Laboratories International, Inc. acquired Agilux Laboratories (US), a provider of bioanalytical services, drug metabolism and pharmacokinetic services, and pharmacology services. This acquisition is expected to compliment Charles River’s non-clinical portfolio and improve the clients’ early-stage research efforts by enabling them to seamlessly transition their drug candidates through the discovery and safety assessment process.

Rat Model Market By Model Type;

  • Outbred Rats
  • Inbred Rats
  • Knockout/Genetically Modified Rats
  • Hybrid/Congenic Rats
  • Conditioned/Surgically Modified Rats
  • Immunodeficient Rats

Download PDF Brochurehttp://www.marketsandmarkets.com/pdfdownload.asp?id=76036494

On the basis of care product, the market is segmented into bedding, cages, feed, and other products (gnotobiotic equipment, water systems, water purification systems, and sound absorption panels). In 2016, the cages segment is expected to command the largest share of the market.

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the Rat Model Market worldwide.

Share this post:

Related Posts

Comments are closed.